GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tenon Medical Inc (NAS:TNON) » Definitions » YoY EBITDA Growth

Tenon Medical (Tenon Medical) YoY EBITDA Growth : 71.96% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Tenon Medical YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Tenon Medical's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 71.96%.

Tenon Medical's EBITDA per Share for the three months ended in Mar. 2024 was $-1.19.


Tenon Medical YoY EBITDA Growth Historical Data

The historical data trend for Tenon Medical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenon Medical YoY EBITDA Growth Chart

Tenon Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
- -1,078.71 -3,945.78 63.40

Tenon Medical Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -152.30 49.22 48.51 83.63 71.96

Tenon Medical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Tenon Medical's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-83.613--228.425)/ | -228.425 |
=63.40 %

Tenon Medical's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-1.185--4.226)/ | -4.226 |
=71.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tenon Medical YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Tenon Medical's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenon Medical (Tenon Medical) Business Description

Traded in Other Exchanges
N/A
Address
104 Cooper Court, Los Gatos, CA, USA, 95032
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Executives
Van Dick Steven M officer: Chief Financial Officer HANSEN MEDICAL, INC., 380 N BERNARDO AVENUE, MOUNTAIN VIEW CA 94043
Richard Ginn director, officer: Chief Technology Officer 104 COOPER COURT, LOS GATOS CA 95032
Steven M Foster director, officer: CEO and President 104 COOPER COURT, LOS GATOS CA 95032
Stephen Hochschuler director C/O TENON MEDICAL, INC., 104 COOPER COURT, LOS GATOS CA 95032
Frank M Fischer director 9701 JERONIMO, IRVINE CA 92618
Richard M Ferrari director 2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Ivan Howard director 104 COOPER COURT, LOS GATOS CA 95032
Robert K Weigle director 104 COOPER COURT, LOS GATOS CA 95032
Ventures Ag Zuhlke 10 percent owner ZURCHERSTRASSE 39J, SCHLIEREN V8 8952